Insider Selling: Vical CAO Unloads 12,500 Shares of Stock (VICL)
Vical (NASDAQ:VICL) CAO Anthony Alan Ramos sold 12,500 shares of the stock on the open market in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $1.25, for a total transaction of $15,625.00. Following the transaction, the chief accounting officer now directly owns 88,364 shares in the company, valued at approximately $110,455. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Shares of Vical (NASDAQ:VICL) traded up 0.81% during mid-day trading on Friday, hitting $1.25. The stock had a trading volume of 25,601 shares. Vical has a 1-year low of $1.01 and a 1-year high of $1.79. The stock’s 50-day moving average is $1.26 and its 200-day moving average is $1.27. The company’s market cap is $110.8 million.
Vical (NASDAQ:VICL) last issued its quarterly earnings data on Thursday, July 31st. The company reported ($0.05) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.05). The company had revenue of $4.50 million for the quarter, compared to the consensus estimate of $1.90 million. During the same quarter in the previous year, the company posted ($0.11) earnings per share. The company’s revenue for the quarter was up 200.0% on a year-over-year basis. Analysts expect that Vical will post $-0.17 EPS for the current fiscal year.
Separately, analysts at Zacks downgraded shares of Vical from an “outperform” rating to a “neutral” rating in a research note on Wednesday, July 23rd. They now have a $1.40 price target on the stock.
Vical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid (NASDAQ:VICL) delivery technologies for the prevention and treatment of serious or life-threatening diseases.
Receive News & Ratings for Vical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vical Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.